Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas [Phase 1, Phase 2]
Phase 1/2 trial evaluating nivolumab with or without ipilimumab in younger patients with recurrent or refractory solid tumors or sarcomas; c…
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: Hodgkin Lymphoma Treatment With Adcetris and Levact in the Old Patient [Phase 1, Phase 2]
Phase 1/2 trial update evaluating the combination of Adcetris and Levact for Hodgkin lymphoma in older patients; study completed.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Multicenter Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab, Bendamustine, Gemcitabine, Vinorelbine (Nivo-BeGEV) in Patients With Relapsed/Refractory Hodgkin Lymphoma [Phase 2]
A Phase 2 multicenter trial evaluating PET-adapted Nivolumab, Bendamustine, Gemcitabine, Vinorelbine in relapsed/refractory Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL [Phase 2]
Phase 2 trial results for pembrolizumab after autologous stem cell transplant in Hodgkin lymphoma, diffuse large B-cell lymphoma, and periph…
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies. [Phase 2]
Phase 2 trial update on conditioning regimens for transplantation of unrelated donor umbilical cord blood in patients with hematologic malig…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-23Clinical Trial Update: Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 trial update on pralatrexate plus romidepsin in relapsed/refractory lymphoid malignancies and multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2022-10-31Clinical Trial Update: A Study of CS1001 in Subjects With Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial update for CS1001 in relapsed or refractory classical Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients [Phase 1, Phase 2]
A clinical trial update evaluating immunotherapy after reduced-intensity conditioning and allogeneic stem cell transplant for poor risk CD30…
-
CLINICAL_TRIALS trial_result · 2022-10-06Clinical Trial Update: Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas [Phase 2]
Phase II trial evaluating alemtuzumab with DA-EPOCH-R in relapsed or refractory Hodgkin lymphoma and diffuse large B-cell lymphoma has compl…
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating nivolumab alone or with vinblastine in classical Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma. [Phase 2]
A Phase 2 trial evaluating brentuximab vedotin in combination with chemotherapy for untreated Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating mocetinostat plus brentuximab vedotin in relapsed or refractory Hodgkin lymphoma has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies [Phase 1, Phase 2]
Phase 1/2 trial of acalabrutinib (ACP-196) in combination with pembrolizumab in hematologic malignancies has completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant, [Phase 3]
Phase 3 trial comparing nivolumab plus brentuximab vedotin vs brentuximab vedotin alone in advanced stage classical Hodgkin lymphoma; trial …
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies [Phase 3]
Phase 3 clinical trial update on stem cell transplantation from partially HLA-m matched related donors for hematologic malignancies; trial c…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma [Phase 1, Phase 2]
This clinical trial update reports on the safety and effectiveness of combining Nivolumab and Daratumumab in patients with multiple myeloma …
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Brentuximab Vedotin Plus DHAP in Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating Brentuximab Vedotin + DHAP in relapsed or refractory classical Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma [Phase 3]
Phase III clinical trial update for Penpulimab in relapsed and refractory classical Hodgkin's lymphoma (NCT05244642).
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin Lymphoma [Phase 1]
Phase 1 trial evaluating T cells engineered with fully-human anti-CD19 and anti-CD20 CARs for B-cell malignancies and Hodgkin lymphoma; the …
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluating Brentuximab Vedotin (Adcetris) in combination with chemotherapy and radiation for younger patients with Stage IIB…
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating PD-1 inhibitor with decitabine followed by autologous stem cell transplant as second-line therapy for relapsed or r…
-
CLINICAL_TRIALS trial_result · 2021-12-07Clinical Trial Update: Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE [Phase 1, Phase 2]
Phase 1/2 trial evaluating brentuximab vedotin in refractory/relapsed Hodgkin lymphoma treated with ICE; study completed.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating gemcitabine and bendamustine in relapsed or refractory Hodgkin lymphoma; completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: 10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial updating the safety and preliminary efficacy of 10-Propargyl-10-Deazaaminopterin in recurrent or refractory lymphoma (non-Ho…
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: R-ABVD vs ABVD-RT in Early Stage Hodgkin's Lymphoma [Phase 3]
Phase 3 trial comparing R-ABVD to ABVD-RT in early-stage Hodgkin lymphoma; study terminated.